KISHBAUCH MICHAEL D
Insider CIK 1076979 · ACHN CEO and President, Director · TLOG Director · CATB Director · PGNX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 16,666 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 26,550 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 14,100 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | D To issuer deriv | 2026-01-23 | 2026-01-23 | 8,333 | — | $0 | 0 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 26,550 | — | $0 | 26,550 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 14,100 | — | $0 | 14,100 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-09 | 8,333 | — | $0 | 8,333 | SEC↗ |
| ATXS Astria Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-21 | 8,333 | — | $0 | 8,333 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2021-06-02 | 2021-06-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2020-06-11 | 2020-06-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 25,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 6,250 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 42,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-07-11 | 2019-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-06-04 | 2019-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2019-01-23 | 2019-01-25 | 42,000 | — | $0 | 42,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2018-06-13 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-06-07 | 2018-06-07 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-02-09 | 2018-02-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2017-07-27 | 2017-07-28 | 6,500 | — | $0 | 6,500 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2017-06-14 | 2017-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2017-01-19 | 2017-01-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2016-06-08 | 2016-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-04-05 | 2016-04-07 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2016-01-25 | 2016-01-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2015-06-10 | 2015-06-11 | 20,000 | $6.72 | $134.4K | 20,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2015-03-02 | 2015-03-04 | 15,342 | $6.65 | $102.0K | 15,342 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | A Award deriv | 2015-01-28 | 2015-01-30 | 10,000 | $5.25 | $52.5K | 30,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2014-12-02 | 2014-12-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | A Award deriv | 2014-11-05 | 2014-11-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-15 | 2014-08-15 | 54,687 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-15 | 2014-08-15 | 133,125 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-15 | 2014-08-15 | 158,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-15 | 2014-08-15 | 150,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-15 | 2014-08-15 | 133,125 | $9.36 | $1.25M | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-15 | 2014-08-15 | 133,125 | $3.28 | $436.6K | 133,125 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-15 | 2014-08-15 | 158,000 | $9.36 | $1.48M | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-15 | 2014-08-15 | 158,000 | $1.05 | $165.9K | 158,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-15 | 2014-08-15 | 150,000 | $9.36 | $1.40M | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-15 | 2014-08-15 | 150,000 | $4.82 | $723.0K | 150,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-15 | 2014-08-15 | 54,687 | $9.75 | $533.2K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-15 | 2014-08-15 | 54,687 | $7.59 | $415.1K | 54,687 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2014-06-17 | 2014-06-19 | 20,000 | $4.47 | $89.4K | 20,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-06-10 | 2014-06-11 | 371,937 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-06-10 | 2014-06-11 | 371,937 | $3.10 | $1.15M | 371,937 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-10 | 2014-06-11 | 371,937 | $7.75 | $2.88M | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2013-12-17 | 2013-12-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2013-10-08 | 2013-10-09 | 6,250 | — | $0 | 6,250 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2013-09-11 | 2013-09-12 | 40,000 | $5.91 | $236.4K | 40,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2012-12-18 | 2012-12-20 | 350,000 | — | $0 | 350,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2012-01-13 | 2012-01-13 | 81,309 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2012-01-13 | 2012-01-13 | 116,997 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2012-01-13 | 2012-01-13 | 81,309 | $1.60 | $130.1K | 81,309 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2012-01-13 | 2012-01-13 | 116,997 | $4.00 | $468.0K | 198,306 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-01-13 | 2012-01-13 | 198,306 | $12.63 | $2.50M | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2012-01-11 | 2012-01-11 | 8,900 | — | $0 | 81,309 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2012-01-11 | 2012-01-11 | 8,900 | $1.60 | $14.2K | 8,900 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-01-11 | 2012-01-11 | 8,900 | $12.50 | $111.3K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2012-01-10 | 2012-01-11 | 90,209 | — | $0 | 90,209 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2012-01-10 | 2012-01-11 | 90,209 | $1.60 | $144.3K | 90,209 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2012-01-10 | 2012-01-11 | 90,209 | $10.01 | $903.0K | 0 | SEC↗ |